Key result
Pharmacy-directed intervention boosts prophylactic aspirin use from 33% to 82% in patients with diabetes.
Why the study?
Adherence to American Diabetes Association guidelines for prophylactic aspirin therapy in ambulatory diabetic patients was suboptimal and needed improvement.
Does a pharmacy-directed intervention improve adherence to prophylactic aspirin therapy in ambulatory patients with diabetes?
Does a pharmacy-directed intervention improve adherence to prophylactic aspirin therapy in ambulatory patients with diabetes?
A simple, pharmacy-directed intervention successfully increased adherence to prophylactic aspirin guidelines in a primary care diabetic population.
Answers are grounded in this paper and cite their sources.
Pharmacy-directed screening may boost aspirin adherence in diabetes; leaves open whether it improves outcomes in randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Faragon et al. (2003) studied Diabetes mellitus (n=85). Pharmacy-directed intervention vs. Baseline was evaluated on Prophylactic aspirin therapy adherence. A pharmacy-directed intervention increased prophylactic aspirin therapy in patients with diabetes from 33% at baseline to 82% at the end of the study.
Synapse has enriched 10 related papers. Consider them for comparative context: